DaisukeKotani· @DaisukeKotani · X·· 4 days agoScore60
Body · original
#ESMO26 | 787RO BRICKET: Ph2 re-treatment with EC in BRAF V600E mCRC @myESMO @OncoAlert https://t.co/yZbBiPWhPE
Heat 11 · 8 likes · 0 replies · 3 reposts
Conference abstracts
NCT06578559NCT06578559matched by - **标题 / Title：** Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC
- **标题 / Title：** Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRCRead the abstract →Source: DaisukeKotani · x.com